background image

Clinical Trials In Rhode Island

Discover hundreds of clinical trials in Rhode Island.
Search clinical trials in Rhode Island by city, condition or phase.

e.g. Respiratory Diseases
Rhode Island•Healthy volunteers: No

Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy

Recruiting
PHASE2

Sponsor:

Waihong Chung

Location:

Providence

Code:

NCT03840057

Conditions

Gastro Intestinal Bleeding

Upper Gastrointestinal Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Azithromycin Injection

Metoclopramide Injectable Solution

Sodium chloride 0.9%

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Providence, Boston, Hartford, New Havenshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

SLC13A5 Deficiency Natural History Study - United States Only

Recruiting

Sponsor:

TESS Research Foundation

Location:

Providence, Dallas, Palo Alto

Code:

NCT06144957

Conditions

Citrate Transporter Deficiency

Epilepsy

Rare Diseases

Movement Disorders

Genetic Disorder

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Study of PYX-106 in Solid Tumors

Recruiting
PHASE1

Sponsor:

Pyxis Oncology, Inc

Location:

Providence, Boston, Fairfax, Cantonshow 6 more

Code:

NCT05718557

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PYX-106

Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence

Recruiting

Sponsor:

Gnankang Sarah Napoe

Location:

Providence, Pittsburgh

Code:

NCT03535857

Conditions

Overactive Bladder Syndrome

Urinary Incontinence, Urge

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

PTNS

A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Regeneron Pharmaceuticals

Location:

Providence, Boston, New Haven, New Yorkshow 8 more

Code:

NCT03972657

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Clear Cell Renal Cell Carcinoma (ccRCC)

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

REGN5678

Cemiplimab

Open Label Placebo to Reduce Prescription Opioid Use

Recruiting

Sponsor:

Brown University

Location:

Providence

Code:

NCT05014230

Conditions

Acute Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Open Placebo

Opioid medication as part of standard care

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

Recruiting
PHASE1

Sponsor:

EMD Serono Research & Development Institute, Inc.

Location:

Providence, Ottawa, Toronto, Atlantashow 4 more

Code:

NCT05464030

Conditions

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

M9140

Bevacizumab

Capecitabine

5-fluorouracil (5-FU)

Folinic acid

EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope

Recruiting

Sponsor:

Butler Hospital

Location:

Providence

Code:

NCT05074030

Conditions

Alcohol Use Disorder

Eligibility Criteria

Sex: All

Age: 18 - 25

Healthy Volunteers: Not accepted

Interventions

Personalized Normative Feedback

Coping-Motive Specific Personalized Feedback Intervention plus an Ecological Momentary Intervention (PFIcope+EMI)

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Recruiting
PHASE3

Sponsor:

Ansun Biopharma, Inc.

Location:

Warwick, Boston, New York, Philadelphiashow 32 more

Code:

NCT03808922

Conditions

Lower Respiratory Tract Infection

Parainfluenza

Immunocompromised

COVID-19

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

DAS181

Placebo

DAS181 COVID-19

DAS181 OL